New strategy uses iPSCs to regulate immune reaction to transplanted tissues

New strategy uses iPSCs to regulate immune reaction to transplanted tissues

New genetic screen for Huntington’s disease Pluripotent stem cells such as embryonic stem cells (ESCs) and iPSCs, which are capable of differentiating into various types of cells, are expected to be an alternative source of grafts for transplantation. But when an organ or tissue from a donor is transplanted, the grafts are rejected and eventually destroyed by the recipient's immune system. The same holds true for cells or tissues derived from pluripotent stem cells. In regenerative medicine, it is therefore important to regulate immune reaction for transplants to succeed. While past research found that it is difficult to efficiently make thymic epithelium cells from iPSCs, the group discovered that the introduction of Foxn1, a pivotal gene in the thymus, to mouse iPSCs helps the efficient differentiation of such cells. The team then transplanted to the recipient mice the thymic epithelium cells derived from iPSCs and skin grafts of genetically compatible donor mice. The results showed that the skin grafts in the recipient mice survived longer when iPSC-derived thymic epithelium cells were transplanted in advance. This suggests it is possible to regulate immune rejection by transplanting immune-regulating cells derived from iPSCs before conducting cell or tissue transplants. This finding will contribute to the advancement of regenerative medicine using cells and tissues derived from iPSCs." Ken-ichiro Seino, researcher Hokkaido University Journal reference: Otsuka, R., et al. (2020) Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival. Scientific Reports . doi.org/10.1038/s41598-019-57088-1 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More